![PDF) Cardiorenal effects of Celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen PDF) Cardiorenal effects of Celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen](https://www.researchgate.net/profile/Christine-West-4/publication/6847758/figure/tbl3/AS:667067770490902@1536052758967/Initiation-of-antihypertensive-and-diuretic-medications_Q320.jpg)
PDF) Cardiorenal effects of Celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/3-Figure1-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet](https://www.thelancet.com/cms/attachment/b77ebcde-64a9-4932-80c7-16627a6b631a/gr1.gif)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis | SpringerLink Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11314690-000000000-00000/MediaObjects/40273_2012_28040323_Tab6.jpg)
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis | SpringerLink
![Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002934305009137-gr1.jpg)
Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/3-Figure2-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study | Annals of the Rheumatic Diseases Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/67/3/323/F1.large.jpg)
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study | Annals of the Rheumatic Diseases
![JCM | Free Full-Text | Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials JCM | Free Full-Text | Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://pub.mdpi-res.com/jcm/jcm-12-03497/article_deploy/html/images/jcm-12-03497-ag-550.jpg?1684233642)
JCM | Free Full-Text | Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/3-Table2-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![PDF] Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac | Semantic Scholar PDF] Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0ba1eaecb9d4c2c151a61cdf33aae52bd1721f09/9-Table5-1.png)
PDF] Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac | Semantic Scholar
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/4-Table4-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia | Health Economics Review | Full Text The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia | Health Economics Review | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13561-015-0053-7/MediaObjects/13561_2015_53_Fig2_HTML.gif)
The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia | Health Economics Review | Full Text
![Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial - The Lancet Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/f897a86b-51ec-469d-937e-c1560a13fb9b/gr1.gif)
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial - The Lancet
![Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016 Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016](https://journals.sagepub.com/cms/10.1177/0300060516628704/asset/images/large/10.1177_0300060516628704-fig2.jpeg)
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/4-Table3-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/2-Table1-1.png)